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The European Journal of Clinical Nutrition (EJCN) is committed to publishing unbiased information and presenting all opinions fairly, in order for our audience to draw their own conclusions from the work that we publish. Truswell's review on the A1/A2 milk hypothesis (Truswell, 2005) The recently published review considers some of the scientific literature relating to the proposed relationship between the A1 and A2 variants of beta casein ('A1' and 'A2', respectively) and Type 1 diabetes mellitus (DM-1) and coronary heart disease (CHD). It extends also to discuss briefly the putative link between the beta casein variants and neurological conditions. The authors of this letter wish to introduce literature and data omitted by the said review believed to be relevant to the considerations presented and the conclusions drawn there from.
Type I diabetes mellitus
The published review provides a critique of selected epidemiology papers and a chronological synopsis of the research trials conducted in relation to DM-1. It is of note that Truswell arrives at a conclusion not collectively shared by the authors of the reviewed papers, and has omitted research reporting parallel correlations in more localised studies concerning Nordic countries (Birgisdottir et al., 2002) and regions of Germany (Wasmuth et al., 1999) .
The review accurately states that it is essential to confirm independently Elliott's experiments with NOD mice; it subsequently presents a multicentre trial as serving this purpose (Beales et al., 2002) . It is important to note that the animals in this trial had free access to cereal grains, a dietary component reported previously by one of the participating researchers as strongly diabetogenic (Scott, 1996) . Additionally, the pregestimil infant formula, which was included in four of eight of the experimental diets, contained a high amount of BCM 7; although not reported in the paper this has been publicly reported (Cone, 2002) and confirmed (Australian Broadcasting Corporation, 2003) . Considering the aforementioned, it would appear that the failure to provide a true 'control' may compromise the hypothesis tested and thus not adequately test for diabetogenic effects of A1 and A2 beta caseins. The presence of BCM-7 and grain-derived diabetogenic factor(s) is likely reflected in the results obtained, with 71 and 73% of the 'control' groups of animals (NOD mice and BB rats, respectively) developing diabetes. 
